You are here » Home » Company » Syncom Formulations (India) Ltd

Syncom Formulations (India) Ltd.

BSE: 524470 Sector: Health care
NSE: N.A. ISIN Code: INE312C01025
BSE 00:00 | 23 May 8.99 -0.15
(-1.64%)
OPEN

9.15

HIGH

9.30

LOW

8.63

NSE 05:30 | 01 Jan Syncom Formulations (India) Ltd Not listed in NSE
OPEN 9.15
PREVIOUS CLOSE 9.14
VOLUME 1411066
52-Week high 19.49
52-Week low 5.76
P/E 39.09
Mkt Cap.(Rs cr) 775
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 9.15
CLOSE 9.14
VOLUME 1411066
52-Week high 19.49
52-Week low 5.76
P/E 39.09
Mkt Cap.(Rs cr) 775
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Syncom Formulations (India) Ltd.

Syncom Formulations (India) Ltd

Incorporated as a private limited company in 1988 Syncom Formulations (India) was converted into a public limited company in Jun.'92. The company set up a manufacturing facility at Palghar Thane to produce pharmaceutical formulations. Commercial production commenced in Apr.'89. Promoters are Kedarmal Bankda Vijay Kumar Bankda and Ajay Kumar Bankda.In addition to pharmaceutical formulations in the ...> More

Syncom Formulations (India) Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   775
EPS - TTM () [*S] 0.23
P/E Ratio (X) [*S] 39.09
Face Value ()   1
Latest Dividend (%)   2.00
Latest Dividend Date 21 Sep 2017
Dividend Yield (%) 0.00
Book Value / Share () [*S] 2.58
P/B Ratio () [*S] 3.48
[*C] Consolidated     [*S] Standalone    

Syncom Formulations (India) Ltd - Financial Results

Particulars ( cr) Mar 2022 Mar 2021 % Chg
Net Sales 58.23 65.54 -11.15
Other Income 5.7 3.76 51.6
Total Income 63.93 69.3 -7.75
Total Expenses 56.35 57.13 -1.37
Operating Profit 7.59 12.17 -37.63
Net Profit 4.76 6.95 -31.51
Equity Capital 86.25 79 -
> More on Syncom Formulations (India) Ltd Financials Results

Syncom Formulations (India) Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Medicamen Biotec 673.30 1.90 822.77
Jagsonpal Pharma 309.95 -4.53 812.07
Themis Medicare 849.10 -3.75 781.17
Syncom Formul. 8.99 -1.64 775.39
Bliss GVS Pharma 71.60 -0.83 743.21
SMS Pharma. 86.50 -0.92 732.66
Guj. Themis Bio. 438.95 -2.84 637.36
> More on Syncom Formulations (India) Ltd Peer Group

Syncom Formulations (India) Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.12
Banks/FIs 0.00
FIIs 0.00
Insurance 0.00
Mutual Funds 0.00
Indian Public 49.68
Custodians 0.00
Other 4.20
> More on Syncom Formulations (India) Ltd Share Holding Pattern

Syncom Formulations (India) Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -9.65% NA 2.48% 2.35%
1 Month -18.72% NA -5.09% -5.57%
3 Month -9.19% NA -5.14% -4.97%
6 Month -8.17% NA -7.46% -7.36%
1 Year 30.29% NA 7.42% 6.85%
3 Year 799.00% NA 39.88% 39.10%

Syncom Formulations (India) Ltd - STOCK STRENGTH

Today's Low/High 8.63
9.30
Week Low/High 8.63
11.00
Month Low/High 7.90
12.00
YEAR Low/High 5.76
19.00
All TIME Low/High 0.14
19.00
.